Familial Gastrointestinal Stromal Tumor Syndrome: Phenotypic and Molecular Features in a Kindred
Frederick P. Li(Dana-Farber Cancer Institute), George D. Demetri(Dana-Farber Cancer Institute), Clara Curiel‐Lewandrowski(University of Arizona), Matt van de Rijn(Stanford University), Anette Duensing(Heidelberg University), Judy E. Garber(Dana-Farber Cancer Institute), Stephen E. Sallan, Michael C. Heinrich(VA Portland Health Care System), Jonathan A. Fletcher(Harvard University), Lowell E. Schnipper(Fox Chase Cancer Center)
Cited by 174
Related Papers
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
|New England Journal of Medicine|2002|4.4k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k